LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 354,815 Value ($000) $0 Avg Close — Range —
Q2 2024
Shares 25,610 Value ($000) $0 Avg Close — Range —
Q1 2024
Shares 34,177 Value ($000) $0 Avg Close — Range —
Q3 2023
Shares 34,540 Value ($000) $0 Avg Close — Range —
Q4 2022
Shares 16,084 Value ($000) $0 Avg Close — Range —
Q1 2022
Shares 46,990 Value ($000) $237 Avg Close — Range —
Q2 2021
Shares 30,500 Value ($000) $495 Avg Close — Range —